相似文献
1
Repeat exposure to active tuberculosis and risk of re-infection.
Med J Aust. 2016 Feb 1;204(2):77-8. doi: 10.5694/mja15.00749.
2
Antituberculosis agents.
Med Clin North Am. 1988 May;72(3):661-8. doi: 10.1016/s0025-7125(16)30764-7.
3
The impact of chemotherapy on the care of patients with tuberculosis.
Am Rev Respir Dis. 1974 Jun;109(6):636-64. doi: 10.1164/arrd.1974.109.6.636.
4
[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
Probl Tuberk Bolezn Legk. 2003(11):22-5.
5
A case of skin and lung tuberculosis: diagnostic difficulties.
G Ital Dermatol Venereol. 2013 Oct;148(5):538-40.
6
Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
Tuberk Toraks. 2012;60(2):136-44.
7
Diagnosis and management of tuberculosis.
Prim Care. 1979 Mar;6(1):43-62.
8
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Dakar Med. 1995;40(2):129-31.
9
[Place of bacteriological examination in the treatment of tuberculosis].
Acta Tuberc Pneumol Belg. 1972 Jul-Oct;63(4):405-8.
10
Tuberculosis: medical management update.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):267-73. doi: 10.1016/j.tripleo.2004.05.012.
引用本文的文献
1
A Framework for Network-Based Epidemiological Modeling of Tuberculosis Dynamics Using Synthetic Datasets.
Bull Math Biol. 2020 Jun 13;82(6):78. doi: 10.1007/s11538-020-00752-9.
Zotero 插件